Compositions and methods for the control, prevention, and treatment of obesity and eating disorders

Details for Australian Patent Application No. 2006230420 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Weyer, Christian; Parkes, David G.; Laugero, Kevin D; Mack, Christine M.

Agent Freehills

Pub. Number AU-B-2006230420

PCT Pub. Number WO2006/105345

Priority 60/675,441 28.04.05 US; 60/760,583 20.01.06 US; 60/666,681 31.03.05 US; 60/667,335 31.03.05 US

Filing date 31 March 2006

Wipo publication date 5 October 2006

Acceptance publication date 24 November 2011

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/105345 Priority application(s): WO2006/105345

24 November 2011 Application Accepted

  Published as AU-B-2006230420

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006230428-Internal biopsy marking

2006230419-Methods for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders